The global antibody testing market was valued at US$ million 7,260.00 in 2021 and is projected to reach US$ 11,578.47 million by 2028; it is expected to grow at a CAGR of 6.9% from 2021 to 2028. The growth of the antibody testing market is mainly attributed to factors such as rising number of Covid-19 cases worldwide, increasing prevalence of chronic diseases and growing geriatric population. However, the antibody testing market is likely to get impacted by the limitations of antibody screening tests during the forecast period.

Antibodies are immunoglobulins, Y-shaped proteins that are produced by the immune system to help stop intruders from harming the body. An antibody test is a screening for the presence of antibodies in the blood. The body makes antibodies when it fights infection, like COVID-19 or when patients get a vaccine, like a flu shot. That’s how immunity to a virus is built. These tests are also called serology tests. Antibody tests help diagnose an autoimmune disease or rule out other conditions with similar signs and symptoms. In addition, antinuclear antibodies (ANA) are a group of autoantibodies produced by an individual's immune system when it cannot adequately distinguish between "self" and "foreign" components. The global antibody testing market is driven by a rising number of COVID-19 cases worldwide, an increasing prevalence of chronic diseases, and a growing senior population. Additionally, growing government support is fueling the growth of antibody testing, which influences the development of the global antibody testing market.

Get Sample Pdf: - https://www.theinsightpartners.com/sample/TIPRE00016492/

 

Rising Number of COVID-19 Cases Worldwide Driving the Antibody Testing Market

According to our new market research study on “Antibody Testing Market to 2028 – Global Analysis and Forecast – by products, indication and end user,” the market is expected to grow from US$ 7,260.00 million in 2021 to US$ 11,578.47 million by 2028. The market is estimated to grow with a CAGR of 6.9% from 2021 to 2028. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Factors such as rising number of covid-19 cases worldwide, increasing prevalence of chronic diseases and growing geriatric population are expected to boost the growth of the global antibody testing market. However, the market is likely to get impacted by the limitations of antibody screening tests during the forecast period.

Antibodies are immunoglobulins, Y-shaped proteins that are produced by the immune system to help stop intruders from harming the body. An antibody test is a screening for the presence of antibodies in the blood. The body makes antibodies when it fights infection, like COVID-19 or when patients get a vaccine, like a flu shot. That’s how immunity to a virus is built. These tests are also called serology tests.

Based on products, the market is segmented into kits, chemical & reagents, and consumables. In 2021, the kits segment accounted for the highest share of the market. The growth of this segment is attributed to a large number of manufacturers like Abbott, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and others and higher adoption of kits in various research processes. The same segment is likely to register the highest CAGR in the global antibody testing market during the forecast period. The kits segment is further sub-segmented into serological test kits, immunoglobulin kits, and lateral flow assay kits. The kit is the most promising segment of the global antibody testing market that will contribute to tremendous growth during the forecast period. Additionally, these products are frequently used in various research processes, which further is expected to propel growth. Further, in response to the growing COVID-19 pandemic and shortages of laboratory-based molecular testing capacity and reagents, multiple diagnostic test manufacturers have developed and begun selling rapid and easy-to-use devices to facilitate testing outside of laboratory settings. These simple test kits are based either on the detection of proteins from the COVID-19 virus in respiratory samples (e.g. sputum, throat swab) or detection, in blood or serum, of human antibodies generated in response to Infectious Diseases.

Global antibody testing market, based on indication is segmented into pregnancy, cardiovascular diseases, autoimmune diseases, infectious diseases, oncology, endocrine diseases and others. The infectious diseases segment held the largest share of the market in 2021, and same segment is anticipated to register the highest CAGR of 8.2% in the market during the forecast period.

Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been urging the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. Over time, real-time polymerase chain reaction tests and antibody tests have emerged as vital techniques for the global healthcare system to manage the outbreak. Antibody detection is essential for differential diagnosis of SARS-CoV-2. It is a test performed by patient serum or plasma with reagent red cells. Determination of specific antibodies to viral and bacterial pathogens and parasites facilitates the correct therapeutic measures to be taken. Antibody testing is critical for implementing an effective and efficient public health strategy to minimize the adverse impact of the COVID-19 pandemic. It should be adopted for important clinical utility cases and support return-to-work strategy globally.

COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frightening especially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade. Till date no definitive treatment against COVID 19 has been established. Hence, lack of definitive therapy offers significant opportunities for global antibody testing market as US FDA has recently approved use of plasma therapy for critically ill COVID 19 patients. In long run antibody testing market will have significant growth prospects as many market players has received emergency use authorization for their newly developed antibody tests. All such developments will add up to the future demand for global antibody testing market.

 

Thermo Fisher Scientific; Abbott Laboratories; Bio-Rad Laboratories, Inc.; Beckton, Dickinson And Company; F. Hoffmann La Roche; Agilent Technologies; DiaSorin; Zeus Scientific; ABCAM; Trinity Biotech are among the leading companies operating in the global antibody testing market. 

 

Buy Now: - https://www.theinsightpartners.com/buy/TIPRE00016492/

AnchorAnchorGlobal Antibody Testing Market, by Region, 2021 (%)

 

Source: The Insight Partners Analysis

 

Geographically, the global antibody testing market has been segmented as follows:

By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Greece, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South and Central America (Brazil, Argentina, and Rest of South and Central America).

Reason To Buy: -

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the antibody testing market.

- Highlights key business priorities in order to assist companies to realign their business strategies.

- The key findings and recommendations highlight crucial progressive industry trends in the global antibody testing market, thereby allowing players across the value chain to develop effective long-term strategies.

- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

List of Companies:-

Thermo Fisher Scientific

Abbott Laboratories

Bio-Rad Laboratories, Inc.

Beckton, Dickinson and Company

F. Hoffmann La Roche

Agilent Technologies

DiaSorin

Zeus Scientific

Abcam

Trinity Biotech

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876